On February 21, 2013, Premier Exhibitions, Inc. (the "Company") entered into agreements to modify its two exhibition tour agreements with Dalian Hoffen Biotechnique Co. Ltd. ("Dalian Hoffen"), in connection with the Company's settlement of its litigation against Dalian Hoffen and related entities. On February 24, 2012, the Company filed suit against Dr. Hong-Jin Sui and Hoffen Global Ltd. (which assigned the agreements to Dalian Hoffen) in the Circuit Court in and for Hillsborough County, Florida. The Company alleged that Messrs. Sui and Hoffen breached certain contractual obligations relating to rights of first refusal and opportunities to match competing offers for the lease of sets of plastinated human anatomical specimens, leading to the opening of a series of exhibitions in Europe competitive with those of the Company.

The two modification agreements reduce the annual license cost to $580 thousand per set annually plus $1 per ticket sold for each ticket over 225,000 per year per contract. The previous agreements included an annual license fee of $1 million per set, with the exception of a one-time one-year reduced fee in 2012 for one set at $700 thousand. The modification agreements also provide for a one-year term with six one-year options thereafter. In addition the modification agreements provide that the Company shall have the exclusive rights to present the specimens in North America. The previous agreements provided the Company with worldwide exclusivity, with the exception of China and Korea.

This summary does not purport to be complete and is qualified by reference to the full text of the modification agreements copies of which all filed as exhibits to this Current Report on Form 8-K and are incorporated herein by reference.

(d) Exhibits.

10.1    First Modification Agreement of Exhibition Tour Agreement Ex 2006A between
        Premier Exhibitions, Inc. and Dalian Hoffen Biotechnique Co. Ltd., dated
        February 21, 2013

10.2    Second Modification Agreement of Exhibition Tour Agreement Ex 2006B
        between Premier Exhibitions, Inc. and Dalian Hoffen Biotechnique Co. Ltd.,
        dated February 21, 2013